Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multidisciplinary medication review during older patient hospitalization according to STOPP/START criteria reduces potentially inappropriate prescriptions, MoPIM cohort study

  • Ortonobes, Sara|||0000-0003-4056-2959
  • Herranz, Susana|||0000-0001-7049-8084
  • Lleal Custey, Marina|||0000-0002-0015-0725
  • Sevilla-Sánchez, Daniel|||0000-0003-2993-6200
  • Jordana, Rosa|||0000-0002-2632-7672
  • Mascaró, Oscar
  • Ferrández, Olivia|||0000-0003-0146-6366
  • De Jaime, Elisabet|||0000-0002-3294-8512
  • Estrada, Rafael
  • Nazco, Gloria Julia|||0000-0001-8265-5753
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
Purpose: Multimorbidity and polypharmacy in older adults converts the detection and adequacy of potentially inappropriate drug prescriptions (PIDP) in a healthcare priority. The objectives of this study are to describe the clinical decisions taken after the identification of PIDP by clinical pharmacists, using STOPP/START criteria, and to evaluate the degree of accomplishment of these decisions. Methods: Multicenter, prospective, non-comparative cohort study in patients aged 65 and older, hospitalized because of an exacerbation of their chronic conditions. Each possible PIDP was manually identified by the clinical pharmacist at admission and an initial decision was taken by a multidisciplinary clinical committee. At discharge, criteria were re-applied and final decisions recorded. Results: From all patients (n = 674), 493 (73.1%) presented at least one STOPP criteria at admission, significantly reduced up to 258 (38.3%) at discharge. A similar trend was observed for START criteria (36.7% vs. 15.7%). Regarding the top 10 most prevalent STOPP criteria, the clinical committee initially agreed to withdraw 257 (34.2%) prescriptions and to modify 93 (12.4%) prescriptions. However, the evaluation of final clinical decisions revealed that 503 (67.0%) of those STOPP criteria were ultimately amended. For the top 10 START criteria associated PIDP, the committee decided to initiate 149 (51.7%) prescriptions, while a total of 198 (68.8%) were finally introduced at discharge. Conclusions: The clinical committee, through a pharmacotherapy review, succeeded in identifying and reducing the degree of prescription inadequacy, for both STOPP and START criteria, in older patients with high degree of multimorbidity and polypharmacy. Trial Registration: NCT02830425.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions, protocol of the multicentre prospective cohort study MoPIM

  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Herranz, Susana|||0000-0001-7049-8084
  • Jordana, Rosa|||0000-0002-2632-7672
  • Gorgas Torner, Maria Queralt|||0000-0001-5523-5171
  • Ortonobes, Sara|||0000-0003-4056-2959
  • Sevilla, Daniel
  • De Jaime, Elisabet|||0000-0002-3294-8512
  • Ibarra, Olatz
  • Martín, Candelaria
Multimorbidity is a major challenge for current healthcare systems and professionals. From the different approaches that have been proposed to analyse this issue, the hypothesis of the existence of association patterns of different chronic conditions is gaining visibility. In addition, multimorbidity can be associated to polypharmacy, which can lead to a higher risk of potentially inappropriate prescribing (PIP) and consequently to adverse drug reactions (ADRs). The general objective of this novel study is to identify the association between PIP, multimorbidity patterns, polypharmacy and the presence of ADRs in older patients admitted for exacerbation of chronic diseases. The MoPIM (morbidity, potentially inappropriate medication) study is a multicentre prospective cohort study of an estimated sample of 800 older (≥65 years) patients admitted to five general hospitals in Spain due to an exacerbation of a chronic disease. Patients referred to home hospitalisation, admitted due to an acute process or with a fatal outcome expected at the time of admission are excluded. Sociodemographic data, chronic morbidities and geriatric syndromes, number of chronic prescribed medications, PIP at admission to hospital and on discharge, according to the newest screening tool of older screening tool of older person's potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria, and ADRs during hospitalisation are being collected. Multimorbidity patterns will be identified using cluster analyses techniques, and the frequency of polypharmacy, PIP and ADRs will be calculated. Finally, the possible relationship between those indicators will be identified through bivariate and multivariate analyses. The project has been approved by the clinical research ethics committees of each centre: Comité Ético de investigación Clínica del Parc Taulí, Comitè Ètic d'Investigació Clínica Osona per a la Recerca i Educació Sanitàries (FORES), Comité de Ètica de la Investigación con Medicamentos (CEIm)-Parc de Salut MAR, Comité Ético de Investigación Clínica de Euskadi, Comité de Ética de Investigación del Hospital Universitario de Canarias. The results will be actively and mainly disseminated through publication in peer-reviewed journals and communications in scientific conferences
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex Differences in Multimorbidity, Inappropriate Medication and Adverse Outcomes of Inpatient Care, MoPIM Cohort Study

  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Lleal Custey, Marina|||0000-0002-0015-0725
  • Sevilla-Sánchez, Daniel|||0000-0003-2993-6200
  • Ortonobes, Sara|||0000-0003-4056-2959
  • Herranz, Susana|||0000-0001-7049-8084
  • Ferrández, Olivia|||0000-0003-0146-6366
  • Corral-Vazquez, Celia|||0000-0002-0621-4590
  • Molist-Brunet, Núria|||0000-0003-0138-6278
  • Nazco, Gloria Julia|||0000-0001-8265-5753
  • Martín-González, Candelaria|||0000-0002-4702-1840
  • Márquez, Miguel Ángel
There is no published evidence on the possible differences in multimorbidity, inappropriate prescribing, and adverse outcomes of care, simultaneously, from a sex perspective in older patients. We aimed to identify those possible differences in patients hospitalized because of a chronic disease exacerbation. A multicenter, prospective cohort study of 740 older hospitalized patients (≥65 years) was designed, registering sociodemographic variables, frailty, Barthel index, chronic conditions (CCs), geriatric syndromes (GSs), polypharmacy, potentially inappropriate prescribing (PIP) according to STOPP/START criteria, and adverse drug reactions (ADRs). Outcomes were length of stay (LOS), discharge to nursing home, in-hospital mortality, cause of mortality, and existence of any ADR and its worst consequence. Bivariate analyses between sex and all variables were performed, and a network graph was created for each sex using CC and GS. A total of 740 patients were included (53.2% females, 53.5% ≥85 years old). Women presented higher prevalence of frailty, and more were living in a nursing home or alone, and had a higher percentage of PIP related to anxiolytics or pain management drugs. Moreover, they presented significant pairwise associations between CC, such as asthma, vertigo, thyroid diseases, osteoarticular diseases, and sleep disorders, and with GS, such as chronic pain, constipation, and anxiety/depression. No significant differences in immediate adverse outcomes of care were observed between men and women in the exacerbation episode.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multimorbidity patterns in COVID-19 patients and their relationship with infection severity, MRisk-COVID study

  • Lleal Custey, Marina|||0000-0002-0015-0725
  • Corral-Vazquez, Celia|||0000-0002-0621-4590
  • Bare Mañas, Montserrat|||0000-0002-7243-3169
  • Comet Monte, Ricard|||0000-0002-7352-779X
  • Herranz, Susana|||0000-0001-7049-8084
  • Baigorri, Francisco
  • Gimeno-Miguel, Antonio
  • Raurich, Maria
  • Fortià, Cristina
  • Navarro, Marta|||0000-0002-3784-4405
  • Poblador-Plou, Beatriz|||0000-0002-5119-5093
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
Several chronic conditions have been identified as risk factors for severe COVID-19 infection, yet the implications of multimorbidity need to be explored. The objective of this study was to establish multimorbidity clusters from a cohort of COVID-19 patients and assess their relationship with infection severity/mortality. The MRisk-COVID Big Data study included 14 286 COVID-19 patients of the first wave in a Spanish region. The cohort was stratified by age and sex. Multimorbid individuals were subjected to a fuzzy c-means cluster analysis in order to identify multimorbidity clusters within each stratum. Bivariate analyses were performed to assess the relationship between severity/mortality and age, sex, and multimorbidity clusters. Severe infection was reported in 9.5% (95% CI: 9.0-9.9) of the patients, and death occurred in 3.9% (95% CI: 3.6-4.2). We identified multimorbidity clusters related to severity/mortality in most age groups from 21 to 65 years. In males, the cluster with highest percentage of severity/mortality was Heart-liver-gastrointestinal (81-90 years, 34.1% severity, 29.5% mortality). In females, the clusters with the highest percentage of severity/mortality were Diabetes-cardiovascular (81-95 years, 22.5% severity) and Psychogeriatric (81-95 years, 16.0% mortality). This study characterized several multimorbidity clusters in COVID-19 patients based on sex and age, some of which were found to be associated with higher rates of infection severity/mortality, particularly in younger individuals. Further research is encouraged to ascertain the role of specific multimorbidity patterns on infection prognosis and identify the most vulnerable morbidity profiles in the community. Registered 4 August 2021 (retrospectively registered).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive Multimorbidity Patterns in Older Patients Are Associated with Quality Indicators of Medication-MoPIM Cohort Study

  • Lleal Custey, Marina|||0000-0002-0015-0725
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Ortonobes, Sara|||0000-0003-4056-2959
  • Sevilla-Sánchez, Daniel|||0000-0003-2993-6200
  • Jordana, Rosa|||0000-0002-2632-7672
  • Herranz, Susana|||0000-0001-7049-8084
  • Gorgas Torner, Maria Queralt|||0000-0001-5523-5171
  • Espaulella-Ferrer, Mariona|||0000-0003-3416-7792
  • Arellano, Marta
  • de Antonio Ferrer, Marta|||0000-0002-4319-797X
  • Nazco, Gloria Julia|||0000-0001-8265-5753
  • Hernández-Luis, Rubén
Multimorbidity is increasing and poses a challenge to the clinical management of patients with multiple conditions and drug prescriptions. The objectives of this work are to evaluate if multimorbidity patterns are associated with quality indicators of medication: potentially inappropriate prescribing (PIP) or adverse drug reactions (ADRs). A multicentre prospective cohort study was conducted including 740 older (≥65 years) patients hospitalised due to chronic pathology exacerbation. Sociodemographic, clinical and medication related variables (polypharmacy, PIP according to STOPP/START criteria, ADRs) were collected. Bivariate analyses were performed comparing previously identified multimorbidity clusters (osteoarticular, psychogeriatric, minor chronic disease, cardiorespiratory) to presence, number or specific types of PIP or ADRs. Significant associations were found in all clusters. The osteoarticular cluster presented the highest prevalence of PIP (94.9%) and ADRs (48.2%), mostly related to anxiolytics and antihypertensives, followed by the minor chronic disease cluster, associated with ADRs caused by antihypertensives and insulin. The psychogeriatric cluster presented PIP and ADRs of neuroleptics and the cardiorespiratory cluster indicators were better overall. In conclusion, the associations that were found reinforce the existence of multimorbidity patterns and support specific medication review actions according to each patient profile. Thus, determining the relationship between multimorbidity profiles and quality indicators of medication could help optimise healthcare processes. Trial registration number: NCT02830425.